Should You Buy Hexo Corp (TSX:HEXO) Ahead of Earnings?

Hexo Corp (TSX:HEXO) has been off to a good start this year, but whether that will continue will likely depend on how well it did during its most recent quarter.

| More on:
edit Cannabis leaves of a plant on a dark background

Image source: Getty Images

Hexo (TSX:HEXO) is expected to release its quarterly earnings later this week, and a good performance could send the stock soaring. Although the stock has risen more than 50% since the start of the year, Hexo is still far from the highs it hit back in October when it was trading at more than $9 per share.

The upcoming quarter is going to be a big one, as it will be the first quarter that earnings will include a full three months’ worth of recreational sales. In its most recent quarter, which included just a few weeks of post-legalization sales, Hexo saw revenues hit $6.7 million, up from just $1.1 million a year ago. Recreational sales of $5.2 million were the main drivers of the growth during the quarter, and that number will be much more significant now.

Why the bottom line might be more important

Investors are expecting sales growth to be significant this quarter, and Hexo stock getting a boost on earnings might very well depend on how close the company is able to get to breaking even. Rising expenses have been a big problem for many cannabis companies, and finding a marijuana stock that is able to stay out of the red, without relying on other income, is very difficult. And being able to do so is one way Hexo can differentiate itself from its peers and gain the attention of investors.

However, last quarter it recorded a net loss of over $12 million, nearly double its top line. If we see that trend continue this quarter, then the stock’s upside might be limited. With Hexo working on the development of beverages with Molson Coors, I wouldn’t expect to see its costs come down any time soon. The one positive is that the company hasn’t been knee deep in acquisitions like some other cannabis companies have been, which means Hexo can focus on its own operations and costs rather than having to worry about integrating other ones and incurring inefficiencies and high costs along the way.

A look at the company’s track record

In three of the past four quarters, Hexo has missed expectations, and the stock has gone on to drop in the days following earnings. Ironically, the one time the company did beat on earnings, it wasn’t enough to keep the stock from falling in price. However, that might not come as a shock, given that it’s usually what the company says about the future and its outlook that dictates price movement, at least in this industry.

Bottom line

Ultimately, there’s not enough evidence here to suggest to me that Hexo will buck the trend and turn a profit. While sales will definitely be up from a year ago, unless we see a big development or a positive update with respect to beverages, I’d be surprised if Hexo were to get a big boost from earnings.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned. The Motley Fool owns shares of Molson Coors Brewing.

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »